MAP2K7 and melanoma: Among many mechanisms that are involved in resistance of melanoma to BRAF/MEK inhibitors is reactivation of the RAF/MEK/ERK pathway, which is found in ~80% of melanomas with acquired resistance to BRAF/MEK inhibitors3.